Co-diagnostics, inc. announces shipment of monkeypox virus test

Salt lake city , july 11, 2022 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has shipped testing reagents for monkeypox virus currently exhibiting a multi-country outbreak to one of its international distributors. according to the world health organization (who), monkeypox is a virus originally transmitted to humans from animals, and then transmitted from one person to another by close contact with lesions, body fluids, respiratory droplets and contaminated materials such as bedding.
CODX Ratings Summary
CODX Quant Ranking